In what is shaping up to be a tough and widespread flu season in the United States, one of the leading medicines used to treat children with the sometimes deadly virus is in short supply.
"There has been strong and early demand for Tamiflu Oral Suspension [OS] and we are experiencing a temporary delay in the packaging of Tamiflu OS,'' said Tara Iannuccillo, a spokeswoman for Roche Holding AG's Genentech unit, which makes the drug.
"A brief shortage of OS is expected through mid-January," she said. "We may be unable to fill complete orders from distributors for a limited time,.'
(Read more: The cost of flu remedies could make you sick)